Alendronate 70Mg Tab

DRUG2 trials

Sponsors

Massachusetts General Hospital, Ain Shams University

Conditions

Anorexia NervosaAtypical Anorexia NervosaBone DensityBone LossEating DisorderOsteoporosis, OsteopeniaRenal Transplant Recipient

Phase 2

Alendronate Versus Denosumab in Kidney Transplant Patients

CompletedNCT04169698

Ain Shams UniversityOsteoporosis, Osteopenia, Renal Transplant Recipient

Start: 2019-10-17End: 2021-05-01Updated: 2021-11-12

Phase 3

Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study

CompletedNCT03292146

Massachusetts General HospitalAnorexia Nervosa, Atypical Anorexia Nervosa, Bone Density +2

Start: 2017-10-25End: 2021-07-22Updated: 2025-11-04

Related Papers

Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy2023-06-162 citations